Anti-Therapeutic Action: treatment resistance

Nutritional strategies in supporting immune checkpoint inhibitor, PI3K inhibitor, and tyrosine kinase inhibitor cancer therapies

mycolabadmin

This review examines how nutrition and food-based interventions can improve cancer treatment outcomes for patients receiving targeted cancer therapies. A Mediterranean-style diet with plenty of fiber (30-50g daily) appears beneficial for patients on immune checkpoint inhibitor therapies by promoting healthy gut bacteria that support immune function. The review also discusses promising research on fermented foods, specific bacterial supplements, mushroom extracts, and fasting approaches as complementary strategies to enhance cancer treatment effectiveness while reducing side effects.

Read More »

Building resilience through healing communities

mycolabadmin

This editorial reviews innovative approaches to mental health care in low- and middle-income countries that blend local healing practices with modern psychiatric treatments. Instead of imposing Western medical models, these programs work with communities to develop culturally appropriate solutions that reduce stigma and improve access to care. Examples include combining spiritual healing traditions with psychiatric care in Ethiopia, using psychedelic-assisted therapy informed by historical trauma in Jamaica, and employing creative arts and mindfulness methods as accessible treatments.

Read More »

Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies

mycolabadmin

Chronic pain affects millions of people and is often resistant to current treatments. This paper suggests that chronic pain emerges from interconnected biological, psychological, and social factors working together as a complex system. The authors propose that psychedelic-assisted therapies could help by breaking rigid thought and behavior patterns that maintain pain, allowing the brain and mind to reorganize in healthier ways, similar to how mindfulness meditation works but potentially more dramatically.

Read More »

A case report of disseminated histoplasmosis not responding to primary treatment by itraconazole

mycolabadmin

A 28-year-old woman developed a serious fungal infection (histoplasmosis) after dental surgery that was initially misdiagnosed as a bacterial infection. Although she was treated with an antifungal medication called itraconazole, her condition worsened with larger lung lesions appearing. When switched to a stronger intravenous antifungal called liposomal amphotericin B, she rapidly improved and fully recovered, demonstrating the importance of adjusting treatment when patients don’t respond as expected.

Read More »

First report of Stemphylium lycopersici keratitis, a complex corneal infection case

mycolabadmin

A 66-year-old man developed a severe corneal infection from a stone chip injury that didn’t improve with standard antibiotics. Doctors discovered the infection was caused by a rare plant fungus called Stemphylium lycopersici, combined with a herpes virus. Using advanced genetic testing (mNGS) to identify the exact pathogens, they prescribed targeted antifungal and antiviral medications along with a corneal transplant, successfully healing the infection and preserving his vision.

Read More »
Scroll to Top